Autoantibodies to glutamic acid decarboxylase in patients with epilepsy are associated with low cortical GABA levels.
Antibodies to glutamic acid decarboxylase (GAD), the major pathway for the synthesis of c-aminobutyric acid(GABA) in humans, are found at elevated levels in a subgroup of patients with chronic epilepsy. To test whether the antibodies were associated with changes in cortical GABA levels we used magne...
Main Authors: | Stagg, C, Lang, B, Best, J, McKnight, K, Cavey, A, Johansen-Berg, H, Vincent, A, Palace, J |
---|---|
Formato: | Journal article |
Idioma: | English |
Publicado em: |
2010
|
Registos relacionados
-
SERUM AUTOANTIBODIES TO GLUTAMIC ACID DECARBOXYLASE ARE ASSOCIATED WITH REDUCED CORTICAL GABA LEVELS IN PATIENTS WITH EPILEPSY
Por: Stagg, C, et al.
Publicado em: (2009) -
The role of anti-glutamic acid decarboxylase autoantibodies (GAD-Ab) in idiopathic late onset cerebellar ataxia (ILOCA)
Por: Muzaimi, M, et al.
Publicado em: (2004) -
Glutamic Acid Decarboxylase Autoantibodies-Related Encephalitis
Por: J Gordon Millichap
Publicado em: (2011-09-01) -
Autoantibodies as a cause of epilepsy
Por: Wroe, S, et al.
Publicado em: (2003) -
Serum antibodies in patients with epilepsy
Por: Lang, B, et al.
Publicado em: (2005)